SIGA Q2 product sales $20.7M, net income $1.8M; receives $113M U.S. order in July

SIGA TECHNOLOGIES INC

2024-Q2 EPS reported $0.17 revenue$47,240,746

Product sales $20.7M in Q2 (vs $1.3M prior year); total revenues $21.8M; net income $1.8M or $0.03 diluted EPS.
Received $113M procurement order from U.S. government for oral TPOXX in July 2024 under BARDA contract.
Delivered $18M of IV TPOXX to U.S. SNS in Q2; $3M oral TPOXX to new ASEAN customer.
Paid special cash dividend of $0.60 per share on April 11, 2024, up $0.15 from prior year.
Amendment with Meridian gives SIGA control over international promotion of oral TPOXX effective June 1, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.